| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |